Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.

Ajit G. Thomas, Krystyna M. Wozniak, Takashi Tsukamoto, David Calvin, Ying Wu, Camilo Rojas, James Vornov, Barbara S. Slusher

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds